Dabigatran's `Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized Trials

Sipahi, IlkeCelik, SedenAkyol, Ahmet2023-02-212023-02-212013-01-0110.1016/j.jacc.2013.05.066https://hdl.handle.net/11443/1529http://dx.doi.org/10.1016/j.jacc.2013.05.066Dabigatran's `Real-World' Data About Risk of Myocardial Infarction and Gastrointestinal Bleeding Contradicts With Randomized TrialsArticleWOS:000323900300020